About Us
The National Respiratory Communications Initiative (NRCI) brings together leading immunization, infectious disease, patient advocacy, and public health organizations to make evidence-based prevention guidance easier to find, understand, and use.
Immunization is one of the most effective ways to reduce the risk of serious respiratory illness. Yet many people remain confused about which vaccines they need, when to get them, and where to go — and fragmented public education efforts can make it hard for trusted information to break through.
To address this challenge, the National Foundation for Infectious Diseases (NFID) in collaboration with partner organizations, including the Association of Immunization Managers (AIM), Immunize.org | National Adult Influenza and Immunization Summit, and Vaccinate Your Family, established NRCI— a collaborative working to ensure that evidence-based information about respiratory disease prevention, including influenza, COVID-19, RSV, and pneumococcal disease, is clear, consistent, and accessible for everyone.
Through coordinated communications and educational resources, NRCI equips individuals, families, and healthcare professionals with the information they need to make informed respiratory health decisions.
Contact Us
For questions about our work or resources — including partnership opportunities — please reach out to: tameit@nfid.org.
For media inquiries, contact: communications@nfid.org.
NRCI Steering Committee
The National Respiratory Communications Initiative (NRCI) brings together leading immunization, infectious disease, patient advocacy, and public health organizations to make evidence-based prevention guidance easier to find, understand, and use. The collaborative effort seeks to ensure that evidence-based information about respiratory disease prevention, including influenza, COVID-19, RSV, and pneumococcal disease, is clear, consistent, and accessible for everyone.
Funder Acknowledgement
This effort is sponsored by NFID in collaboration with CDC, with support from professional societies and patient advocacy partners, in-kind support from Walmart and Sanofi Vaccines, and unrestricted educational grants from GSK, Merck & Co., Inc., Moderna, Sanofi, and Seqirus. NFID policies prohibit funders from controlling program content.